Medify Solutions Ltd.

Medify Solutions Limited (Pink Sheets - MDFY) - to Acquire Voice 2 Voice Limited

    Stafford, England (ots/PRNewswire) - Medify Solutions Limited (Pink Sheets - MDFY) confirmed today that the  Group has successfully concluded the negotiations to acquire, as a fully  owned subsidiary, Voice 2 Voice Limited in the UK. Voice 2 Voice will  continue to operate under its existing management and commercial terms  including all current and prospective contracts. This acquisition delivers, mobile, fixed line, data and voice services into one new Group. In addition , the management team of Voice 2 Voice will bring a critical strengthening  and depth into the executive team of Medify Solutions.

    What is Voice 2 Voice (www.voice2voice.co.uk)? A totally independent,  leading UK fixed line and hosted IP telecommunication and integrated voice  network company. Specializing in multi-site UK and European businesses in  the commercial, governmental and Healthcare sectors. Combining  telecommunications focus with a dynamic and flexible approach to meeting  customers' business needs has helped us to build a reputation for dealing  with PBX and networking requirements. Voice 2 Voice have established  themselves as a Tier 2 Service Level Provider to AlwaysON to empower voice  and data resellers to use converged voice and data communications efficiently and at a significantly lower cost.

    What does this mean to investors and Medify Solutions? The Medify Group  now has a wholly owned suite of fixed line and mobile solutions to market  directly to the general enterprise and Global Healthcare markets. The group  benefits immediately with a product and go to market infrastructure, with  both businesses gaining synergies and economies of scale. The immediate  Voice 2 Voice revenue delivered as a subsidiary will be booked to the Group financial accounts of Medify Solutions Limited US. This consolidation strengthens both companies for the expansion of Voice 2 Voice and the MedifyRemote roll-out. This creates a suite of telecoms services, installation, support, fixed line, mobile, voice and data to the enterprise  and Healthcare sectors; under a single Group entity.

    Market Capitulation & Revenues - Voice 2 Voice has invoiced and forecast income to the value of US$1.6m in their current financial year, at a  gross profit margin in approximately 40%. Based on reoccurring revenue for  Voice 2 Voice of US$5m over the next 24 months, the additional market Cap of  the Medify Group, based on Voice 2 Voice alone, would typically be in the  region of US$15m dollars. This would equate to a share price increase in the  region of US$1.50 (post reverse stock split).

    This news release contains forward-looking statements that are subject  to certain risks and uncertainties that may cause actual results to differ  materially from those projected on the basis of such forward-looking  statements. The words "estimate," "project," "intends," "expects," " believes," and similar expressions are intended to identify forward-looking  statements. Such forward-looking statements are made based on management's  beliefs, as well as assumptions made by, and information currently  available to, management pursuant to the "safe-harbour" provisions of the Private Securities Litigation Reform Act of 1995. For a more complete description of these and other risk factors that may affect the future  performance of Medify Solutions Limited, see "Risk Factors" in the  Company's Annual Report on Form 10-KSB and its other filings with the  Securities and Exchange Commission. Readers are cautioned not to place  undue reliance on these forward-looking statements, which speak only as of  the date made and the Company undertakes no obligation to disclose any  revision to these forward-looking statements to reflect events or  circumstances after the date made or to reflect the occurrence of  unanticipated events.

ots Originaltext: Medify Solutions Ltd.
Im Internet recherchierbar: http://www.presseportal.ch

Contact:
For further information: Press Office email:
press@medifysolutions.com; Enquires to: Chris Hill,
+44-(0)-845-03-44-095



Weitere Meldungen: Medify Solutions Ltd.

Das könnte Sie auch interessieren: